Skip to main content

Remote Job Finders (RJF)

Gilead sets blockbuster bar for Yeztugo’s first full year on the market

With initial patients coming back for their second dose of Gilead’s twice-yearly PrEP injection, the pharma thinks the shot will hit $1 billion in sales this year, serving as “a cornerstone in Gilead’s revenue growth story.”

Increased capital boosts biotech R&D job postings, employment

Biotech R&D job postings live on BioSpace rose for the fourth straight month in April, and a CBRE report shared similar findings for employment. The head of CBRE’s U.S. life sciences practice discusses what’s behind the growth and the current job market.
Scroll to top